Cerus (CERS) Change in Account Payables (2010 - 2026)
Cerus (CERS) posted Change in Account Payables of $1.9 million for Q2 2026, down 53.05% sequentially from $4.1 million in Q1 2026, and down 30.7% YoY from $2.8 million in Q2 2025.
Cerus (CERS) Change in Account Payables (2010 - 2026) Analysis & Trends
Cerus has reported Change in Account Payables for 17 years, with the latest figure at $1.9 million in Q2 2026.
- Quarterly Change in Account Payables fell 30.7% year-over-year to $1.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $4.0 million (down 69.91% YoY) and the FY2025 annual result came in at $5.7 million, up 487.61% from the prior year.
- Change in Account Payables eased to $1.9 million in Q2 2026 per CERS's latest filing, from $4.1 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $6.3 million in Q4 2024 and troughed at -$15.4 million in Q4 2023.
- A 5-year average of -$105944.4 and a median of $1.1 million in 2022 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2023 and 2025: Change in Account Payables tumbled 3416.99% in 2023, then jumped 510.69% in 2025.
- Over 5 years, Change in Account Payables stood at $465000.0 in 2022, then sank by 3416.99% to -$15.4 million in 2023, then surged by 141.16% to $6.3 million in 2024, then sank by 62.78% to $2.4 million in 2025, then retreated by 17.73% to $1.9 million in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered $1.9 million, $4.1 million, and $2.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 71.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -200.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 4.30 Mn |
| 10 | Cerus | 562.58 Mn | 506.32 Mn | 29.53 Mn | 1.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.94 Mn |
| Jun 30, 2026 | 1.94 Mn |
| Mar 31, 2026 | 4.14 Mn |
| Mar 31, 2026 | 4.14 Mn |
| Dec 31, 2025 | 2.36 Mn |
| Dec 31, 2025 | 2.36 Mn |
| Sep 30, 2025 | -4.48 Mn |
| Sep 30, 2025 | -4.48 Mn |
| Jun 30, 2025 | 2.81 Mn |
| Jun 30, 2025 | 2.81 Mn |
| Mar 31, 2025 | 5.04 Mn |
| Mar 31, 2025 | 5.04 Mn |
| Dec 31, 2024 | 6.35 Mn |
| Dec 31, 2024 | 6.35 Mn |
| Sep 30, 2024 | -1.00 Mn |
| Sep 30, 2024 | -1.00 Mn |
| Jun 30, 2024 | -683,000.00 |
| Jun 30, 2024 | -683,000.00 |
| Mar 31, 2024 | -6.14 Mn |
| Mar 31, 2024 | -6.14 Mn |